Services Offered - Sales-Force Effectiveness Assessment, Sales channel planning and restructuring, Business Development, KOL/Market access, distribution planning. Highly experienced in Orthopaedics across Europe and with very strong network in Orthopaedic oncology, Joint Replacement, Trauma and Sports Med.

Active portfolio management and seeking out new products and supplier that complemented the Hospital Innovations portfolio. Actively managing evaluations and trails and working with new and existing suppliers to source new products and sales opportunities.

Initially Sales Business manager looking after U.K. and Ireland the role changed in early 2016 to include managing all sales channels outside of the US (Around 90% of Total WW Sales). A hands on role managing various internal projects across, operations, Information Management and Customer services. Responsibility for all sales channels including direct, agents and various international distributors. • Developed and shaped true performance culture in whole business. • Lead marketing team and developed and strengthened ‘Extreme Ortho’ Brand. • Remodelled sales channel in UK and Europe. • Introduced true price segmentation resulting in improved customer engagement and increased profitability. • Hit UK and OUS budget for 4 consecutive years. • 2017 17% Growth despite acquisition and change. • Management of key distributor network in Europe. • Led strategic development of both Revision and Trauma market. (Endo Prosthetic Use) • Strategic integration partner for Stryker/SIW acquisition. • Commercial Head for OUS business since acquisition (£10.7m of £12.7m Globally). • OJOU Tender, Private Hospital, procurement hub and NHS lead.

Business unit Director with P&L responsibility for Ortho Reconstruction business. Second line manger of a team of 6 RSM's and 42 Territory Managers with an aggregate sales value of just under £50m. • Delivered full regional restructure with minimal people and sales loss and meeting spend/saving targets. • 18% Growth in Core knee sales in 2011 and 7% in 2012 • 15% Core Hip Growth in 2012 • Exceeded budget for UK Recon in 2011 and 2012 despite MoM crisis. • Successfully reduced inventory in the field by $3m over two years whilst growing core sales. • Implemented ‘Tender Excellence’ Strategy in 2012 • Helped develop and deliver price segmentation planning for Orthopaedics. • NHS, Private Hospital and Procurement Hub lead. • Made savings of over £800k in SG&A by rationalising fellowship and meeting spend (2013) • Responsible for Talent Management.

Managing the reconstructive, and for a large period the trauma business in Wales and the South West, I manage a team of five TM's and am responsible for recruitment, coaching, strategy and pricing for the region. My role is to put the planning, processes and people in place to ensure that the region hits its sales target. I choose to take a hands on approach in the field, helping to develop my teams' technical and sales skills, whilst at the same time building credible relationships with our KOLs. • Built a team from scratch due to previous high turnover. • Team kept together in full. • At point of promotion 4/5 Recon and 4/4 Trauma reps had hit all quarterly targets. • Successfully managed and adapted to change demonstrated through merger with Plus Ortho. • Repeatedly lead the way with innovative products, Legion, PFJ, Deuce, Visionaire and also Journey Uni. • Largest revision knee business in S&N UK. • Largest regional TSF growth 2010. • Planned and delivered £1m hip and knee growth (From £0) in Newport over a two year period. • Delivered AOC as pilot Visionaire site in 2010. (Largest in Europe) • Highest ranked Regional Team in 2010.

Ranked number 1 Recon rep in 2006 117% of target. (Territory missed in Q1)Supported and delivered first Legion business in South West in 2006.Delivered three new Legion and four new Gen 2 users in 2007.Set up AOC as VSP centre for PFJ, Gen2 and Legion.104% target in 2007.

- Liaison between SPUK and NHS. Developing projects and partnerships with key customers in both PCOs and secondary care. Implementation and promoting of Guidelines that facilitated the growth of SPUK products and pre-marketing of SPUK pipeline products (2005 Neupro).

The launch of Plavix and promotion of Plavix and Lipostat to both primary and secondary care customers on the South East Wales territory. Specific responsibility for the Royal Gwent and Llandough hospital accounts. Key Achievements:Successfully Launched Plavix into both primary and secondary care. Number 1 ranked TM in 1999 and 2000Solely responsible for the development, implementation and roll out of ITC CRM training module.Selected for HQ based training role

Sole responsibility for the promotion of Combivent on the South East Wales territory to both primary and secondary care. Working with the nurse specialist team to implement audits of GP respiratory patients to ensure growth of BI products.